Gene Therapy Shows Lasting Two-Year Gains in Infants With Severe Spinal Muscular Atrophy
A two-year follow-up of 64 Italian children shows that gene therapy with onasemnogene abeparvovec continues to deliver motor gains well ...
A two-year follow-up of 64 Italian children shows that gene therapy with onasemnogene abeparvovec continues to deliver motor gains well ...
A groundbreaking study led by the University of Minnesota Medical School has received notable recognition following a three-year funding grant ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine